Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Bachmann

Showing results (11-20 of 111) with videos related to

Pageof 12
Sort By:
Drug Discovery Today|May 30, 2001
Challenges and new approaches for the vaccine industryM F. Bachmann, G T. Jennings
Annual Review of Immunology|January 1, 1997
Neutralizing antiviral B cell responsesM F Bachmann, R M Zinkernagel
Current Opinion in Immunology|April 1, 1994
In vivo versus in vitro assays for assessment of T- and B- cell functionM F Bachmann, T M Kündig
Immunology Today|December 1, 1996
The influence of virus structure on antibody responses and virus serotype formationM F Bachmann, R M Zinkernagel
Allergy|August 26, 2016
Allergen-specific immunotherapy: is it vaccination against toxins after all?M F Bachmann, T M Kündig
Journal of Immunological Methods|June 12, 1999
Influenza virus: a novel method to assess viral and neutralizing antibody titers in vitroM F Bachmann, B Ecabert, M Kopf
The Journal of Experimental Medicine|June 22, 1999
CD8(+) T cells mediate CD40-independent maturation of dendritic cells in vivoC Ruedl, M Kopf, M F Bachmann
European Journal of Immunology|August 15, 2000
The antigen dose determines T helper subset development by regulation of CD40 ligandC Ruedl, M F Bachmann, M Kopf
The Journal of Experimental Medicine|November 24, 1999
CD2 sets quantitative thresholds in T cell activationM F Bachmann, M Barner, M Kopf
Medical Microbiology and Immunology|December 1, 1994
Immunization with recombinant protein: conditions for cytotoxic T cell and/or antibody inductionM F Bachmann, H Hengartner, R M Zinkernagel
Pageof 12

Showing results (11-20 of 111) with videos related to

Sort By:
Pageof 12
Drug Discovery Today|May 30, 2001
Challenges and new approaches for the vaccine industryM F. Bachmann, G T. Jennings
Annual Review of Immunology|January 1, 1997
Neutralizing antiviral B cell responsesM F Bachmann, R M Zinkernagel
Current Opinion in Immunology|April 1, 1994
In vivo versus in vitro assays for assessment of T- and B- cell functionM F Bachmann, T M Kündig
Immunology Today|December 1, 1996
The influence of virus structure on antibody responses and virus serotype formationM F Bachmann, R M Zinkernagel
Allergy|August 26, 2016
Allergen-specific immunotherapy: is it vaccination against toxins after all?M F Bachmann, T M Kündig
Journal of Immunological Methods|June 12, 1999
Influenza virus: a novel method to assess viral and neutralizing antibody titers in vitroM F Bachmann, B Ecabert, M Kopf
The Journal of Experimental Medicine|June 22, 1999
CD8(+) T cells mediate CD40-independent maturation of dendritic cells in vivoC Ruedl, M Kopf, M F Bachmann
European Journal of Immunology|August 15, 2000
The antigen dose determines T helper subset development by regulation of CD40 ligandC Ruedl, M F Bachmann, M Kopf
The Journal of Experimental Medicine|November 24, 1999
CD2 sets quantitative thresholds in T cell activationM F Bachmann, M Barner, M Kopf
Medical Microbiology and Immunology|December 1, 1994
Immunization with recombinant protein: conditions for cytotoxic T cell and/or antibody inductionM F Bachmann, H Hengartner, R M Zinkernagel
Pageof 12